相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury
Veronique Plantevin Krenitsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor
Veronique Plantevin Krenitsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Role of JNK in Mammary Gland Development and Breast Cancer
Cristina Cellurale et al.
CANCER RESEARCH (2012)
Axonal degeneration as a therapeutic target in the CNS
Paul Lingor et al.
CELL AND TISSUE RESEARCH (2012)
U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis
Albert Deisseroth et al.
CLINICAL CANCER RESEARCH (2012)
Tofacitinib for the treatment of rheumatoid arthritis
Cristiano A. F. Zerbini et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2012)
JNK signaling is the shared pathway linking neuroinflammation, blood-brain barrier disruption, and oligodendroglial apoptosis in the white matter injury of the immature brain
Lan-Wan Wang et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Inhibition of JNK by a Peptide Inhibitor Reduces Traumatic Brain Injury-Induced Tauopathy in Transgenic Mice
Hien T. Tran et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Delayed Inhibition of c-Jun N-Terminal Kinase Worsens Outcomes after Focal Cerebral Ischemia
Yoshihiro Murata et al.
JOURNAL OF NEUROSCIENCE (2012)
The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria
Yi Zhao et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2012)
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
Ulf Schulze-Topphoff et al.
PLOS ONE (2012)
The JNK Inhibitor XG-102 Protects against TNBS-Induced Colitis
Kirstin Reinecke et al.
PLOS ONE (2012)
Differential Requirement for c-Jun N-terminal Kinase 1 in Lung Inflammation and Host Defense
Jos Van der Velden et al.
PLOS ONE (2012)
JNK3 Maintains Expression of the Insulin Receptor Substrate 2 (IRS2) in Insulin-Secreting Cells: Functional Consequences for Insulin Signaling
Saida Abdelli et al.
PLOS ONE (2012)
JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate
Anette Huebner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Janus kinase inhibitors
E. Ostermeier et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2012)
Molecular Mechanisms of Neonatal Brain Injury
Claire Thornton et al.
NEUROLOGY RESEARCH INTERNATIONAL (2012)
Development of JNK2-Selective Peptide Inhibitors That Inhibit Breast Cancer Cell Migration
Tamer S. Kaoud et al.
ACS CHEMICAL BIOLOGY (2011)
JNK-1 Deficiency Limits Macrophage-Mediated Antigen-Induced Arthritis
Monica Guma et al.
ARTHRITIS AND RHEUMATISM (2011)
Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase
Surya K. De et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacement
R. Jeffrey Neitz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor
Simeon Bowers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) Inhibitors
Yuanjun He et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration
Simeon Bowers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors
Romain Noel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis and SAR of 2-Phenoxypyridines as novel c-Jun N-terminal kinase inhibitors
Xinyi Song et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration
Gary D. Probst et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Levodopa Activates Apoptosis Signaling Kinase 1 (ASK1) and Promotes Apoptosis in a Neuronal Model: Implications for the Treatment of Parkinson's Disease
Elizabeth A. Sabens Liedhegner et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene
Wei Wu et al.
CIRCULATION (2011)
The bottleneck of JNK signaling: Molecular and functional characteristics of MKK4 and MKK7
Wiebke Haeusgen et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
c-Jun N-terminal Kinase (JNK-1) Confers Protection against Brief but Not Extended Ischemia during Acute Myocardial Infarction
Jianqin Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Design and Characterization of a Potent and Selective Dual ATP- and Substrate-Competitive Subnanomolar Bidentate c-Jun N-Terminal Kinase (JNK) Inhibitor
John L. Stebbins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
JNK: A Stress-Activated Protein Kinase Therapeutic Strategies and Involvement in Alzheimer's and Various Neurodegenerative Abnormalities
Sidharth Mehan et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Excitotoxicity-induced endocytosis mediates neuroprotection by TAT-peptide-linked JNK inhibitor
Anne Vaslin et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Requirement of c-Jun NH2-Terminal Kinase for Ras-Initiated Tumor Formation
Cristina Cellurale et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay
Peter H. p Reinhart et al.
NEUROBIOLOGY OF DISEASE (2011)
C-Jun N-terminal kinase induces axonal degeneration and limits motor recovery after spinal cord injury in mice
Kazuhiro Yoshimura et al.
NEUROSCIENCE RESEARCH (2011)
Activation of JNK Signaling Mediates Amyloid-β-Dependent Cell Death
Meghana Tare et al.
PLOS ONE (2011)
c-Jun N-terminal kinase (JNK) signaling: Recent advances and challenges
Marie A. Bogoyevitch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors
Surya K. De et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK
Roy K. Hom et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
JNK inhibition and inflammation after cerebral ischemia
Corinne Benakis et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
The c-Jun N-terminal kinase inhibitor SP600125 is neuroprotective in amygdala kindled rats
Xu Chen et al.
BRAIN RESEARCH (2010)
c-Jun N-terminal kinase signaling pathway in excitotoxic cell death following kainic acid-induced status epilepticus
Giada Spigolon et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Synthesis, Biological Evaluation, X-ray Structure, and Pharmacokinetics of Aminopyrimidine c-jun-N-terminal Kinase (JNK) Inhibitors
Ted Kamenecka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Small Molecule JNK (c-Jun N-Terminal Kinase) Inhibitors
M. Arshad Siddiqui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers
Chiara Ferrandi et al.
Multiple Sclerosis Journal (2010)
Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease
Steven P. Braithwaite et al.
NEUROBIOLOGY OF DISEASE (2010)
Jnk2 Effects on Tumor Development, Genetic Instability and Replicative Stress in an Oncogene-Driven Mouse Mammary Tumor Model
Peila Chen et al.
PLOS ONE (2010)
The Role of JNK Proteins in Metabolism
Sara N. Vallerie et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance
Guadalupe Sabio et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
MAPK signaling in inflammation-associated cancer development
Pengyu Huang et al.
PROTEIN & CELL (2010)
Regulation of JNK and p38 MAPK in the immune system: Signal integration, propagation and termination
Gonghua Huang et al.
CYTOKINE (2009)
c-Jun N-terminal Kinase-1 From Hematopoietic Cells Mediates Progression From Hepatic Steatosis to Steatohepatitis and Fibrosis in Mice
Yuzo Kodama et al.
GASTROENTEROLOGY (2009)
Blockage by SP600125 of Fc Receptor-Induced Degranulation and Cytokine Gene Expression in Mast Cells is Mediated Through Inhibition of Phosphatidylinositol 3-Kinase Signalling Pathway
Shuhei Tanemura et al.
JOURNAL OF BIOCHEMISTRY (2009)
Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes
Adeel Ijaz et al.
KIDNEY INTERNATIONAL (2009)
SPECIFIC ACTIVITIES OF INDIVIDUAL c-Jun N-TERMINAL KINASES IN THE BRAIN
W. Haeusgen et al.
NEUROSCIENCE (2009)
Inhibitors of c-Jun N-terminal kinases-JuNK no more?
Marie A. Bogoyevitch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
c-Jun N-Terminal Kinase 2 Deficiency Protects Against Hypercholesterolemia-Induced Endothelial Dysfunction and Oxidative Stress
Elena Osto et al.
CIRCULATION (2008)
All JNKs can kill, but nuclear localization is critical for neuronal death
Benny Bjorkblom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
Lijian Hui et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
K252a prevents nigral Dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways
Jing Pan et al.
MOLECULAR PHARMACOLOGY (2007)
Gini coefficient: A new way to express selectivity of kinase inhibitors against a family of kinases
Piotr P. Graczyk
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The c-jun kinase/stress-activated pathway: Regulation, function and role in human disease
Gary L. Johnson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Suppression of alloreactivity and allograft rejection by SP600125, a small molecule inhibitor of c-Jun N-terminal kinase
Akihiro Tabata et al.
TRANSPLANTATION (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brain
Elise H. Tran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway
Yongjun Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
JM Schattenberg et al.
HEPATOLOGY (2006)
The isoform-specific functions of the c-Jun N-terminal kinases (JNKs): differences revealed by gene targeting
Marie A. Bogoyevitch
BIOESSAYS (2006)
Biozzi mice: Of mice and human neurological diseases
S Amor et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Physiological regulation of the β-amyloid precursor protein signaling domain by c-Jun N-terminal kinase JNK3 during neuronal differentiation
WT Kimberly et al.
JOURNAL OF NEUROSCIENCE (2005)
Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: A new therapeutic target in Parkinson's disease
RM Silva et al.
MOVEMENT DISORDERS (2005)
Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type 1 diabetes
A Jaeschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and non-nuclear pathways
QH Guan et al.
BRAIN RESEARCH (2005)
Targeting the JNK Signaling Pathway for Stroke and Parkinson's Diseases Therapy
Chia-Yi Kuan et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
Specific pathophysiological functions of JNK isoforms in the brain
S Brecht et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease
S Hunot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Targeting JNK3 for the treatment of neurodegenerative disorders
L Resnick et al.
DRUG DISCOVERY TODAY (2004)
A critical role of neural-specific JNK3 for ischemic apoptosis
CY Kuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
T Borsello et al.
NATURE MEDICINE (2003)
The specificities of protein kinase inhibitors: an update
J Bain et al.
BIOCHEMICAL JOURNAL (2003)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2
K Nicolson et al.
INTERNATIONAL IMMUNOLOGY (2002)
C-jun NH2-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8+ T cell activation
D Conze et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis
ZN Han et al.
ARTHRITIS AND RHEUMATISM (2002)
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
BL Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cell-permeable peptide inhibitors of JNK novel blockers of beta-cell death
C Bonny et al.
DIABETES (2001)
Activation of JNK3α1 requires both MKK4 and MKK7:: Kinetic characterization of in vitro phosphorylated JNK3α1
J Lisnock et al.
BIOCHEMISTRY (2000)
分享论文
